SK500402007A3 - Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu - Google Patents

Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu

Info

Publication number
SK500402007A3
SK500402007A3 SK50040-2007A SK500402007A SK500402007A3 SK 500402007 A3 SK500402007 A3 SK 500402007A3 SK 500402007 A SK500402007 A SK 500402007A SK 500402007 A3 SK500402007 A3 SK 500402007A3
Authority
SK
Slovakia
Prior art keywords
manufacture
pharmaceutical composition
composition containing
free base
same
Prior art date
Application number
SK50040-2007A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Neuro�N�
Milan Bocko
Original Assignee
Peter Neuro�N�
Milan Bocko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK500402007(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Peter Neuro�N�, Milan Bocko filed Critical Peter Neuro�N�
Publication of SK500402007A3 publication Critical patent/SK500402007A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
SK50040-2007A 2005-06-22 2006-06-22 Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu SK500402007A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500912 2005-06-22
PCT/DK2006/000366 WO2006136169A2 (en) 2005-06-22 2006-06-22 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Publications (1)

Publication Number Publication Date
SK500402007A3 true SK500402007A3 (sk) 2008-05-06

Family

ID=37546630

Family Applications (1)

Application Number Title Priority Date Filing Date
SK50040-2007A SK500402007A3 (sk) 2005-06-22 2006-06-22 Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu

Country Status (39)

Country Link
EP (3) EP2325177A1 (lv)
JP (5) JP4906852B2 (lv)
KR (5) KR20120064140A (lv)
CN (2) CN101928269A (lv)
AR (2) AR055062A1 (lv)
AT (3) ATE497500T1 (lv)
AU (2) AU2006261452B2 (lv)
BG (1) BG66086B1 (lv)
BR (1) BRPI0612295A2 (lv)
CA (2) CA2612827C (lv)
CY (1) CY1112392T1 (lv)
CZ (3) CZ299906B6 (lv)
DE (2) DE112006001619T5 (lv)
DK (3) DK1896439T4 (lv)
EA (2) EA201001108A1 (lv)
EE (1) EE00773U1 (lv)
ES (2) ES2319073B1 (lv)
FI (2) FI20077133A (lv)
GB (2) GB2442160B (lv)
HR (1) HRP20110093T4 (lv)
HU (1) HUP0800135A3 (lv)
IL (1) IL187454A0 (lv)
IS (1) IS8705A (lv)
LT (1) LT5550B (lv)
LV (1) LV13677B (lv)
MX (1) MX2007015328A (lv)
MY (2) MY143239A (lv)
NO (2) NO20080359L (lv)
PL (2) PL1896439T5 (lv)
PT (1) PT1896439E (lv)
RS (1) RS51575B2 (lv)
SG (1) SG169358A1 (lv)
SI (1) SI1896439T2 (lv)
SK (1) SK500402007A3 (lv)
TR (2) TR200708792T1 (lv)
TW (2) TWI358407B (lv)
UA (1) UA86536C2 (lv)
WO (1) WO2006136169A2 (lv)
ZA (2) ZA200711066B (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
EP2134325A2 (en) * 2007-03-01 2009-12-23 Aurobindo Pharma Limited Stable solid dosage forms of an antidepressant
EP2595979B1 (en) 2010-07-23 2016-04-06 H. Lundbeck A/S Process for the purification of pharmaceutically acceptable salts of escitalopram
CN103360353A (zh) * 2013-08-07 2013-10-23 中国药科大学 草酸艾司西酞普兰杂质的制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) * 2017-04-10 2018-11-14 東和薬品株式会社 エスシタロプラム医薬組成物
CN110711198B (zh) * 2018-07-12 2022-03-15 山东大学 D-甘露糖在制备抗抑郁药物中的应用
KR102331187B1 (ko) 2019-04-09 2021-11-26 주식회사 라이트팜텍 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JPH05222041A (ja) * 1992-02-13 1993-08-31 Mitsubishi Gas Chem Co Inc アデニン誘導体の精製法
RU2161954C2 (ru) * 1994-01-27 2001-01-20 Дзе Борд оф Регентс оф Дзе Юниверсити оф Оклахома Быстрорастворяющиеся во рту лекарственные формы
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
CA2325909C (en) 1997-06-30 2006-07-04 Beloit Technologies, Inc. Method and apparatus for the high speed application of coating to a traveling paper web
EP1015416B1 (en) 1997-07-08 2001-09-19 H. Lundbeck A/S Method for the preparation of citalopram
CZ292911B6 (cs) 1997-11-11 2004-01-14 H. Lundbeck A/S Způsob výroby citalopramu
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US7510728B2 (en) * 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
RU2273472C2 (ru) * 2000-10-16 2006-04-10 Дайити Фармасьютикал Ко., Лтд. Лекарственный состав, быстро распадающийся в ротовой полости, и способ его изготовления
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
IL147226A (en) * 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
ATE222899T1 (de) * 2000-12-28 2002-09-15 Lundbeck & Co As H Verfahren zur herstellung von reinem citalopram
KR20040030609A (ko) * 2001-05-01 2004-04-09 하. 룬트벡 아크티에 셀스카브 경상이성체성 순수 에스시탈로프람의 용도
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
CA2451915C (en) * 2001-07-31 2010-09-21 H. Lundbeck A/S Crystalline composition containing escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
EP2228060A1 (en) * 2002-05-03 2010-09-15 Skyepharma Canada Inc. Oral dosage forms comprising fenofibrate
KR20050086933A (ko) 2002-12-23 2005-08-30 하. 룬트벡 아크티에 셀스카브 브롬화수소산에스시탈로프람 및 이의 제조방법
CN1510024A (zh) * 2002-12-24 2004-07-07 北京德众万全药物技术开发有限公司 可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
CA2524806C (en) * 2003-05-07 2011-07-12 Akina, Inc. Highly plastic granules for making fast melting tablets
ES2688193T3 (es) * 2003-10-15 2018-10-31 Fuji Chemical Industry Co., Ltd. Comprimido de disgregación rápida en la cavidad oral
AU2003282383A1 (en) * 2003-11-20 2005-06-08 Natco Pharma Limited A process for the preparation of high purity escitalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
CA2558198A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts

Also Published As

Publication number Publication date
PL1896439T5 (pl) 2016-01-29
GB2442160B (en) 2010-01-20
EA200800102A1 (ru) 2008-04-28
HRP20110093T4 (hr) 2015-02-27
GB0811164D0 (en) 2008-07-23
GB2448834A (en) 2008-10-29
PL384185A1 (pl) 2008-06-23
CZ299906B6 (cs) 2008-12-29
PL1896439T3 (pl) 2011-04-29
JP5731957B2 (ja) 2015-06-10
KR20080018191A (ko) 2008-02-27
JP2009046506A (ja) 2009-03-05
DK1896439T3 (da) 2011-02-28
EP1896439B1 (en) 2011-02-02
DE602006019961D1 (de) 2011-03-17
LT5550B (lt) 2009-03-25
GB2448834B (en) 2010-01-20
AT10983U1 (de) 2010-02-15
AT11883U1 (de) 2011-06-15
CN101928269A (zh) 2010-12-29
ES2356838T3 (es) 2011-04-13
CA2612827C (en) 2010-11-30
MY143239A (en) 2011-04-15
IL187454A0 (en) 2008-02-09
BG66086B1 (bg) 2011-03-31
WO2006136169A3 (en) 2007-10-18
CA2612827A1 (en) 2006-12-28
EA019239B1 (ru) 2014-02-28
SI1896439T2 (sl) 2014-12-31
JP4906852B2 (ja) 2012-03-28
DK200900284A (da) 2009-02-27
WO2006136169A2 (en) 2006-12-28
CN101189220A (zh) 2008-05-28
DE112006001619T5 (de) 2008-06-12
LT2008005A (en) 2008-10-27
IS8705A (is) 2008-01-14
ZA200901698B (en) 2010-04-28
CZ2007898A3 (cs) 2008-01-23
UA86536C2 (ru) 2009-04-27
EP2385044A1 (en) 2011-11-09
HUP0800135A2 (en) 2008-06-30
JP2009179635A (ja) 2009-08-13
CA2646780A1 (en) 2006-12-28
ATE497500T1 (de) 2011-02-15
GB0724557D0 (en) 2008-01-23
GB2442160A (en) 2008-03-26
TWI347942B (en) 2011-09-01
KR20100133023A (ko) 2010-12-20
CY1112392T1 (el) 2015-12-09
RS51575B2 (sr) 2018-02-28
TR201000625T1 (tr) 2010-03-22
DK200800075A (da) 2008-03-15
AU2006261452B2 (en) 2010-02-04
DK1896439T4 (en) 2015-01-12
MX2007015328A (es) 2008-02-15
TW200740785A (en) 2007-11-01
BG110024A (bg) 2008-05-30
EE00773U1 (et) 2008-10-15
NO20101777L (no) 2008-01-18
KR20110084341A (ko) 2011-07-21
BRPI0612295A2 (pt) 2011-01-04
EP1896439B2 (en) 2014-10-15
JP2008546724A (ja) 2008-12-25
SI1896439T1 (sl) 2011-03-31
AU2006261452A1 (en) 2006-12-28
AU2010200844A1 (en) 2010-04-01
EP2325177A1 (en) 2011-05-25
CZ300686B6 (cs) 2009-07-15
AR055062A1 (es) 2007-08-01
AR079750A2 (es) 2012-02-15
MY143252A (en) 2011-04-15
EA201001108A1 (ru) 2011-02-28
ES2356838T5 (es) 2015-01-26
ES2319073B1 (es) 2010-02-26
CZ301286B6 (cs) 2009-12-30
ZA200711066B (en) 2009-07-29
LV13677B (en) 2008-05-20
JP2009179634A (ja) 2009-08-13
ES2319073A1 (es) 2009-05-01
NO20080359L (no) 2008-01-18
SG169358A1 (en) 2011-03-30
KR101340815B1 (ko) 2013-12-11
FI20080548A (fi) 2008-10-07
EP1896439A2 (en) 2008-03-12
TW201130808A (en) 2011-09-16
TR200708792T1 (tr) 2008-05-21
HRP20110093T1 (hr) 2011-03-31
KR20110033310A (ko) 2011-03-30
TWI358407B (en) 2012-02-21
JP4415056B2 (ja) 2010-02-17
FI20077133A (fi) 2007-12-20
KR20120064140A (ko) 2012-06-18
HUP0800135A3 (en) 2009-01-28
JP2012072168A (ja) 2012-04-12
RS51575B (en) 2011-08-31
PT1896439E (pt) 2011-02-15

Similar Documents

Publication Publication Date Title
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
SK500402007A3 (sk) Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL225207A (en) A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL186523A0 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
EP1808225A4 (en) CAPACITY PRODUCT, METHOD OF MANUFACTURE AND INK COMPOSITION
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
HK1112916A1 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3-
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
IL215897A0 (en) Pharmaceutical composition at the equilibrium state comprising 4-hydroxy tamoxifen and method for making it
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
HUP0401523A3 (en) Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them
PL1783105T3 (pl) Kompozycja zaprawowa, sposób jej wytwarzania i jej zastosowanie
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
IL190830A0 (en) Stable pharmaceutical formulaions containing escitalopram and bupropion
IL189177A0 (en) Process for producing carcosporamide and pharmaceutical compositions containing cercosporamide

Legal Events

Date Code Title Description
FA9A Suspended patent application procedure at request of an applicant